LOADING
Comparing Microsoft Corporation (MSFT) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | ABBV |
|---|---|---|
| Price | $489.08 | $263.03 |
| Change Today | +1.21% | -0.73% |
| Market Cap | $3.59T | $468.2B |
| P/E Ratio | 26.9 | 74.6 |
| Forward P/E | 24.4 | 18.9 |
| PEG Ratio | 1.57 | 0.43 |
| EPS | $17.93 | $3.55 |
| Revenue Growth (YoY) | 17.7% | 10.2% |
| Profit Margin | 40.3% | 9.8% |
| Return on Equity | 34.0% | 62.3% |
| Dividend Yield | 0.76% | 2.61% |
| Beta | 1.10 | 0.28 |
| 52-Week High | $549.20 | $267.47 |
| 52-Week Low | $348.54 | $189.40 |
| Volume | 132K | 16K |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.